In 1993 was created Pacific Horizon Ventures, which is appeared as VC. The main office of represented VC is situated in the Seattle. The company was established in North America in United States.
Besides them, we counted 1 critical employee of this fund in our database.
The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, iScience Interventional, Koronis Pharmaceuticals. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Pacific Horizon Ventures, startups are often financed by Asset Management Ventures (AMV), Prism Venture Management, DeNovo Ventures. The meaningful sponsors for the fund in investment in the same round are Asset Management Ventures (AMV), Prism Venture Management, DeNovo Ventures. In the next rounds fund is usually obtained by Prism Venture Management, Three Arch Partners, DeNovo Ventures.
The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2011. The high activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Pacific Horizon Ventures performs on 7 percentage points less the average number of lead investments. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies.
Related Funds
Funds with similar focus
Fund Name | Location |
Blindspot | Canada, Ontario, Toronto |
CAR Inc. | Beijing, Beijing, China |
CM Diamant | - |
Defence and Security Accelerator | - |
Early-Stage NYC Fund | New York, New York, United States |
Gateway | California, Oakland, United States |
Gelita AG | Baden-Württemberg, Baden-Wurttemberg, Germany |
Grupo RPP | - |
High Alpha | Indiana, Indianapolis, United States |
Institutional Investor | New York, New York, United States |
Kataweb | Italy, Lazio, Rome |
KohFounders | California, Los Angeles, United States |
Laurier Start-up Fund | Canada, Ontario, Waterloo |
Nippon Broadcasting System | Chiyoda, Japan |
NorthStar Capital | Minneapolis, Minnesota, United States |
Okta | California, San Francisco, United States |
QSP | - |
Sallie Mae | Delaware, Newark, United States |
Sapphire Lake Investment | Beijing, Beijing, China |
Vision Brazil Investments | Brazil, Espirito Santo, Pernambuco |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ViaCyte | $25M | 16 Jul 2007 | San Diego, California, United States | ||
iScience Surgical | $15M | 31 Mar 2005 | California, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
iScience Interventional | $7M | 18 Mar 2003 | California, United States | ||
iScience Surgical | $7M | 17 Mar 2003 | California, United States | ||
TransMolecular | $9M | 14 Sep 2000 | Birmingham, Alabama, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ViaCyte | $25M | 16 Jul 2007 | San Diego, California, United States | ||
iScience Surgical | $15M | 31 Mar 2005 | California, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
iScience Interventional | $7M | 18 Mar 2003 | California, United States | ||
iScience Surgical | $7M | 17 Mar 2003 | California, United States | ||
TransMolecular | $9M | 14 Sep 2000 | Birmingham, Alabama, United States |